AGING in humans is associated with a progressive decrease in skeletal muscle mass and strength (sarcopenia) that contributes to frailty and falls. The age-associated changes in body composition result from lower levels of anabolic hormones, neuromuscular alterations, and a general decline in muscle protein turnover (1–3). The frailty of old age has emerged as an important public health problem because it impairs mobility and quality of life and increases the risk of falls and the use of health care resources (4–6). Therefore, recent years have witnessed a growing interest in the use of anabolic interventions for augmenting muscle mass and function in older men. The term sarcopenia, originally coined by Rosenberg (4) and recently reviewed by the National Institutes of Aging (5), refers to the involuntary loss of skeletal muscle mass and strength. This is in contrast to wasting, the involuntary loss of weight driven largely by inadequate nutrition, and cachexia, the involuntary loss of fat-free mass (FFM), especially body cell mass, generally resulting from a state of hypermetabolism and hypercatabolism (6). The etiology of sarcopenia is currently unknown. Holloszy (5) identified several possible mechanisms leading to sarcopenia, including loss of α motor neurons in the spinal column, impairment of endogenous growth hormone, androgen and estrogen production, inadequate protein intake, dysregulation of catabolic cytokines, and reduced physical activity. Mortality in the elderly is primarily associated with atherosclerosis, cancer, and dementia. In an increasing number of the elderly men and women, however, loss of muscle mass and strength is an important determinant of the individual’s ability to live an independent life (7). There is no consensus on whether sarcopenia should be viewed as a disease or process of normative aging (4). It has been argued that, because loss of muscle mass occurs even during the course of successful aging, sarcopenia should be considered a disease only when it induces disability (4). There is also no consensus on what threshold of muscle loss should be used to define sarcopenia. The magnitude of the public health problem posed by sarcopenia is not known (8). Baumgartner et al. (9) examined the prevalence of sarcopenia in Hispanic and non-Hispanic white elderly men and women in New Mexico. Sarcopenia was defined as the relative muscle mass that was two sds below the sex-specific means of the Rosetta Study reference data (10) for young adults, aged 18–40 yr. The study (9) demonstrated that the prevalence of sarcopenia increased from 13% to 24% in persons under 70 years of age. Nearly half of all persons over 80 years of age met this definition of sarcopenia. The study also demonstrated that sarcopenia was associated with a 3- to 4-fold increased likelihood of disability in elderly people, independently of age, sex, obesity, ethnicity, socioeconomic status, chronic morbidity, and health behaviors (9). Another cross-sectional survey performed by Melton (11) in Olmsted County in Minnesota used slightly different thresholds for defining sarcopenia and reported lower prevalence rates. Based on an age-stratified, random sample of the population of Rochester, Minnesota, this survey verified the findings of Baumgartner et al. (9) that lean body mass decreases progressively after the second decade of life in both men and women. Age-related losses in fat-free mass, appendicular muscle mass, and total muscle mass are all linear in both men and women, and there was no significant difference in the slope of the regression line before 50 and after 50 years of age. The prevalence of sarcopenia in individuals over 20 years of age was 2–3% and in those over 65 years of age, approximately 10% (11). Taken together, these two epidemiological studies provide evidence that sarcopenia is an important public health problem. In the two-compartment model of body composition, body weight is the combination of fat mass and fat-free mass. Fat-free mass, in turn, is the combination of body cell mass, extracellular fluid, and the extracellular solids such as collagen and bone mineral. Body cell mass can be further divided into the fat-free portion of cells within muscle, viscera, and the immune system. Muscle cell mass is an important determinant of muscle strength, whereas the sum of visceral and muscle body cell mass predicts energy requirements (6). Thus, changes in body composition with aging, especially in the FFM component, have important implications for functional status and survival (6, 13). Weight gain in adults is associated with an increase in absolute and percent fat mass (14). In women, body weight increases between the ages of 40 and 50 yr and remains stable thereafter; percent body fat is also stable until 40 yr of age and increases from 28% to 35% between 40 and 50 yr of age (15). In another cross-sectional study (16) of men and women 18–85 yr of age who used total body potassium, percent fat increased from 18% to 36% and 33% to 44% in men and women, respectively. In addition to an overall increase in adiposity, aging is associated with a more central distribution of fat (14). The composition of lean tissues also changes with advancing age. Men experience a more rapid muscle loss between the ages of 41 and 60 yr, whereas women experience the rapid loss after the age of 60 (17). Total body nitrogen, calcium, water, and bone mineral content also decline with age (18–21). More recent epidemiological surveys suggest that age-associated decrease in skeletal muscle mass starts after the second decade of life in both men and women and is slowly progressive thereafter. The principal component of the decrease in fat-free mass is the loss of muscle mass; there is little change in nonmuscle lean mass (18, 19). Between 20 and 80 yr of age, the cumulative decline in skeletal muscle mass amounts to 35–40% (22, 23). The depletion of muscle mass does not result in weight loss because of the corresponding accumulation of body fat (24). Muscle atrophy results from a gradual and selective loss of muscle fibers. The number of fibers in the vastus lateralis muscle from cadavers of older men is 23% lower than in young men (26). There is a preferential atrophy of fast-twitch, type II fibers (24), in part because of their reduced reinnervation capacity than type I fibers (26). There is an increase in intramuscular fat and connective tissue (27). These changes reduce the contractile tissue volume available for locomotive and metabolic functions and the increased amount of connective tissue presumably acts as a friction brake to slow contractile velocity (24, 28). Most studies of muscle mass and body composition have relied on cross-sectional data. Many of these studies have not taken into account individual variation due to the level of physical activity, nutritional status, and disease. There is also a paucity of data on ethnic differences in body composition. Sarcopenia has been identified as a contributor to disability in old age (29, 30). Walking, stair climbing, rising from a chair, and load carrying represent functional activities that deteriorate with sarcopenia. Loss of muscle mass, particularly the preferential loss of type II fibers (24), results in diminished strength and power-generating capacity (31). There is a significant correlation between strength and leg power and maximal walking speed and stair-climbing height (31–34). Rantanen and Avela (34) have described critical ranges of leg power for different walking speeds, suggesting that below the critical range the probability of walking at a particular speed is low. Falls are a serious consequence of the loss of muscle strength and power. Leg weakness and decreased peak torque and power are associated with impaired gait characteristics, such as small steps and slow speeds (35) and a history of falling (36, 37). Because strength is fundamental to the neuromuscular function that supports mobility (37), loss of strength below a critical threshold may be associated with an increased risk of falls. Therefore, interventions that increase muscle mass, strength, and power in the lower extremity may reduce the risk of falling. The maximal oxygen uptake rate (VO2max) defines the capacity for endurance exercise (22). Both decreased muscle mass (23) and decreased oxidative capacity of skeletal muscle (38) with aging contribute to the 1% annual decline in maximal aerobic capacity. Resistance training can increase VO2max in the elderly (39); this suggests that increasing muscle mass can increase maximal aerobic power. Sarcopenia contributes to the decline of aerobic capacity, thus limiting the extent to which older individuals may participate in a variety of activities and retain their independence. Therefore, interventions that augment muscle mass can help older men maintain or regain their ability to perform daily functional activities and live independently. Approximately 20% of muscle weight is protein; therefore, changes in muscle mass will likely be associated with alterations in muscle protein turnover (which includes muscle protein synthesis and break down) (14, 24). Whole body protein synthesis declines from birth to old age (40). However, when protein turnover rates are normalized to FFM, there is no difference between young and old subjects (41, 42). Because older people lose FFM but not weight, it is possible that the difference observed in whole body protein synthesis in the elderly is due to their increased fat mass (14). Also, the muscle contributes<30% to whole body protein turnover; therefore, small changes in muscle protein synthesis or breakdown are difficult to detect with measurements of whole body protein turnover. Indeed, the fractional synthesis rates of mixed or myofibrillar protein are lower from muscle biopsy samples in old people as compared with young people (42–44). Standardized exercise programs, testosterone, and amino acids can stimulate the synthetic rates of total muscle protein (44), as well as myofibrillar proteins (45). In contrast, high-protein meals do not enhance the stimulation of myofibrillar synthesis induced by resistance exercise (45). Because amino acids alone can stimulate muscle protein anabolism in young and older subjects (46), it is unlikely that alterations of muscle protein metabolism in the elderly are due to a defect in amino acid transport. There are alterations in the synthesis rates of individual muscle proteins in older individuals. Compared with younger subjects, the middle-aged and older men and women have significantly lower synthetic rates of myosin heavy chain, an important contractile protein (47). The fractional myofibrillar protein synthesis rate (the rate of synthesis per gram of myofibrillar protein already present) is 28% slower in older subjects (42). The reduced myofibrillar protein synthesis in the elderly is not due to a reduction in the availability of mRNAs encoding actin and myosin (48) and may be the result of posttranslational events. Protein turnover is important for maintaining the mass of structural and contractile proteins and enzyme function (24). There is a 40% decrease in mitochondrial protein synthesis rates in middle-aged subjects, but no further decrease in older subjects (49). The changes in mitochondrial function may contribute to alterations in muscular endurance and fatigability and contractility (24). Although it is now possible to measure synthesis and breakdown rates of specific muscle proteins and to study their regulation (14, 47, 49, 50), these methods are invasive and are not clinically applicable to older individuals with sarcopenia. We have little information about the genetic regulation of skeletal muscle protein turnover in humans. Aging is associated with changes in several trophic factors (51), including the male sex hormones and the growth hormone There is an age-associated decrease in total and levels in men of studies demonstrated an decrease in levels in older men levels are the result of changes at levels of the to is diminished in older to androgen is and the of the is and can also levels as a levels are lower in older men than those in younger older men have or leading to that older men be to the of The androgen number and are decreased in of the aging However, in the older men have increased than decreased to androgen on and This of androgen of muscle and bone to in older men has not been There is no consensus on the levels that can be used to define androgen in older men. We do not have a clinically of androgen Total level below or levels below 60 especially associated with of androgen There is evidence that declines with age. Because is an anabolic it has been that of the changes in body composition with age may be to decreased The of and to exercise and stimulation are decreased in older men and women, as compared with young men growth levels are lower in older men than young the levels in older of are in the for young men levels with maximal aerobic capacity and physical and with in older men. a peak in protein levels decrease after the decade of life and are in by the in and metabolism is different in than it is in humans. The of are lower in than humans Also, in the than the are the of of and in humans increase progressively at about yr. a peak in the levels and this rate of decline after the decade of This has to the that the changes in body composition, and of old age may be to The decline in and the decline of the as a that is in the body to and specific has been described for in and do not whether has than those to and There is that of increase FFM, muscle and maximal strength in men levels with fat mass, particularly visceral fat mass; however, not all studies a reduction in fat mass after of men The of on muscle strength and physical function in older men are unknown. studies have examined the anabolic of on body composition in older men with levels per or for to older men with levels of In this FFM increased by after In another study of to older men with levels of was associated with a increase in strength, but body composition not et al. reported a significant increase in FFM and strength in men with a for et al. reported increased fractional muscle protein synthesis and muscle in the older men. of in young and older men of in young and older men have examined the of in older men. et al. older men over the age of 50 yr with of with or per for a of There was a in strength after The FFM not change In another demonstrated significant in FFM, strength, and bone in older men with who with a of for et al. examined the of by means of a per for in men over 65 years of age. The older men over the age of 65 to a or to of men the increased from to in men with the but not change in men. was associated with a significant decrease in fat mass reduction in fat mass, and an increase in lean body mass increase in lean body mass, as compared with men. the change in bone mineral was not significantly different between the and men that bone increased by about in men with levels of but not change in those with levels of or This not significantly increase the strength of and was well and the of was not significantly different between the and There significant in levels in men Taken together, the studies of and et al. that in older men with levels increases in lean body mass, bone mineral and strength. We do not whether can clinically changes in muscle reduce falls and or quality of life in older men. Also, the of in particularly the the population that is the at risk for and have not been The of of older particularly with to the risk of disease and remains to be Most studies of the androgen have used of It is that a may The data on the between levels and muscle strength are to the and of for use in older men. are in that in older men increases lean body mass and decreases fat mass Because methods of body composition are to changes in body water, it is possible that increase in lean body mass may There are differences in to and in to In women experience in to than men In contrast, men are more to than women men have a in a decrease in fat mass and and a change in of bone and than women. of growth hormone in older men of growth hormone in older men does not increase or and strength or endurance in older men This is in contrast to the young adults with who in muscle strength, and exercise capacity We do not the of in of to older individuals is associated with significant including and It is possible that lower of may muscle the at Because of the associated with and the of in muscle the use of in elderly remains The to may be by sex et al. the of alone and in combination with and estrogen in older men and women, yr of age. In this alone increased muscle mass and muscle cross-sectional of and was associated with a increase in muscle cross-sectional and a reduction in percent fat than These data suggest that the of on body composition may be by of of In recent several such as and and nutritional have available in health levels have been with an increased risk of in women, in and the decline of during aging is available in health and over the as nutritional and is as a for including obesity, and muscle Most of these are on studies performed in in the levels are lower than the levels in humans. The of used in the studies have been and should be viewed as of of to is associated with in immune function and reduction of fat mass, and of the of atherosclerosis, and In of obesity, the rate of weight However, these data have to be in to women is associated with in testosterone, and levels However, the studies of no change or a of and levels Although studies a significant reduction in fat mass with the daily rates of in young daily for have no change in body composition. et al. reported that of in older subjects increased levels and increased however, another study by the reported no change in lean body mass. et al. demonstrated that daily of the and levels in older men and women to those in young men and women, and significantly increased and muscle strength in men However, have no change in body composition after of daily for Therefore, it remains whether has in humans and of is a hormone by the and of both and is an in the androgen and estrogen is from and is to by the enzyme or to by the is available and is primarily to and people in The number of people is not The prevalence of use of in the has been to be men and women the prevalence of use of was in It is likely that use is even more Because levels of have been to increase muscle and strength people that will have anabolic study reported that a increased levels significantly in two women The magnitude of the increase however, was studies have examined the of on levels in men. In study was to men for and levels but levels not protein synthesis not increase In another study and to men for levels increased but testosterone, and levels not change study examined the of men with daily for in an in which of by in which the was not The total therefore, was which may have been to significant changes in body composition. men the sample may have been small to detect but significant changes in levels or muscle strength The in this study resistance exercise alone and resistance exercise the of alone not Therefore, do not at whether has a in is to have on exercise It has been argued that of into and the of the to to as an important of energy for muscle The is that increased of within the muscle can help to and during However, data on the of on body composition and muscle function are because of of study studies of body weight and lean body mass with have no significant change in body composition or muscle In an study by et al. subjects into of but no exercise but no exercise and with or a of resistance exercise to increase in strength or The study also to significant changes in body composition, as by lower muscular The of on body composition and muscle function to be The that has and lean body mass, skeletal muscle and strength study by et al. to on body composition and muscle In this men to or in addition to in resistance training for The that not enhance muscle strength, or lean body mass in older men during a resistance training from on which of are are muscle mass is to changes in physical activity. Therefore, the decrease in with advancing age may contribute to the of sarcopenia The loss of muscle mass may to further reduction in the level of physical activity, thus the of skeletal muscle strength is the only known that can of the functional changes with aging or resistance training a progressive increase in over which a muscle Muscle strength increases in to training resistance that or of the the of amount of weight that can be with The increase in muscle with strength training is largely the result of increased of contractile protein The mechanisms by which strength training increases muscle mass are not The of strength training on muscle strength and body composition in older men have been examined in several studies of strength training on strength and body composition in older men of strength training on strength and body composition in older men The of strength training the magnitude of in muscle strength and in the the of strength training is only increases in muscle strength are of lower extremity strength training in a of older men was associated with a increase in peak and of the with no change in muscle cross-sectional In contrast, a resistance training and per at of the in older men to a and increase in and strength, respectively. cross-sectional by increased and the cross-sectional of type I and type II fibers increased by and respectively. In daily of increased suggesting an increase rate of myofibrillar protein turnover. of the subjects in this study also a per The no on strength however, body weight, and cross-sectional all increased in subjects the nutritional suggesting that may the magnitude of changes in body composition as a result of strength training in the elderly have reported data on the of strength training on muscle strength and muscle et al. have demonstrated the of progressive resistance training in elderly individuals. These have reported in muscle strength, muscle cross-sectional and walking an of resistance exercise training in elderly men and women age, The strength of the increased cross-sectional increased and gait speed increased These data that even in the the capacity of the aging to to increased levels of physical is More strength training can be to the elderly and may of the loss in function Aging is associated with significant in fat mass, and an increase in The principal component of the decline in fat mass is a decrease in muscle mass due to a reduction in muscle protein content and synthesis rates. The loss of FFM is associated with loss of muscle strength and function and with increased disability and (6). The body composition changes in old age are and may be to the changes in hormone production, protein and The evidence to the use of or in sarcopenia is only to be Although and can augment lean body mass in older do not whether the body composition changes during these anabolic interventions are associated with in muscle physical and Also, of the data have been in older men with functional The of these interventions in the elderly and the old have not been The of interventions such as and has not been therefore, the risk to remains into the possible of in the elderly is in the has the public and interest in this
No takes yet. Share an insight, caveat, or question.
Bross et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: